Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 2Weight Loss 1Unspecified Adult Solid Tumor, Protocol Specific 1Neoplasms 1Malnutrition 1Fasting 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Docetaxel 171Radiotherapy 144Magnetic Resonance Spectroscopy 142Leuprolide 112Prednisone 108enzalutamide 102Radiosurgery 101Abiraterone Acetate 94Androgen Antagonists 91Goserelin 83bicalutamide 81gallium 68 PSMA-11 70Surveys and Questionnaires 63apalutamide 57Specimen Handling 56acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 55Radiation 47Gonadotropin-Releasing Hormone 45Standard of Care 44Biopsy 44Brachytherapy 42Radiotherapy, Intensity-Modulated 40Blood Specimen Collection 40darolutamide 39abiraterone 39cabazitaxel 35Exercise 35Carboplatin 33Pluvicto 32Triptorelin Pamoate 31

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Prostatic Neoplasms × Nutritionists × Clear all
NCT03824652 2026-05-07

WALNUTS for POWER: Polyphenols, Omega-3 Fatty Acids, Weight Loss, and EneRgy

Cedars-Sinai Medical Center

Phase 2 Recruiting
50 enrolled
Genitourinary

Prostatic Neoplasms

NCT03679260 2023-03-30

Carbohydrate Restricted Diet Intervention for Men on Prostate Cancer Active Surveillance

Cedars-Sinai Medical Center

Phase 2 Completed
22 enrolled
Genitourinary

Prostatic Neoplasms, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡